84 related articles for article (PubMed ID: 28369)
21. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
22. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
23. [Nephropathy associated with hypocomplementemic urticarial vasculitis: A case report and literature review].
Boyer A; Gautier N; Comoz F; Hurault de Ligny B; Aouba A; Lanot A
Nephrol Ther; 2020 Mar; 16(2):124-135. PubMed ID: 31928955
[TBL] [Abstract][Full Text] [Related]
24. [Vasculitic urticaria: study of 12 cases].
Hassan ML; Perez Cejudo JA; Yachi del Pino E; Schroh RG
Med Cutan Ibero Lat Am; 1990; 18(3):179-84. PubMed ID: 2263094
[TBL] [Abstract][Full Text] [Related]
25. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
26. [Hypocomplementemic urticarial vasculitis].
Jachiet M; Flageul B; Bouaziz JD; Bagot M; Terrier B;
Rev Med Interne; 2018 Feb; 39(2):90-98. PubMed ID: 28457680
[TBL] [Abstract][Full Text] [Related]
27. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
[TBL] [Abstract][Full Text] [Related]
28. Studies of urticaria and acute serum sickness with the C1q precipitin test.
Lieberman P; Rice MC; Mallette JE
Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
30. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
31. Crescentic membranoproliferative glomerulonephritis and hypocomplementemic urticarial vasculitis.
Enríquez R; Sirvent AE; Amorós F; Pérez M; Matarredona J; Reyes A
J Nephrol; 2005; 18(3):318-22. PubMed ID: 16013022
[TBL] [Abstract][Full Text] [Related]
32. Recurrent pericarditis and cardiac tamponade in a patient with hypocomplementemic urticarial vasculitis syndrome.
Babajanians A; Chung-Park M; Wisnieski JJ
J Rheumatol; 1991 May; 18(5):752-5. PubMed ID: 1865426
[TBL] [Abstract][Full Text] [Related]
33. The binding site for C1q on IgG.
Duncan AR; Winter G
Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
[TBL] [Abstract][Full Text] [Related]
34. C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and function.
Ghebrehiwet B; Galanakis DK
Behring Inst Mitt; 1993 Dec; (93):214-23. PubMed ID: 8172570
[TBL] [Abstract][Full Text] [Related]
35. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases.
O'Loughlin S; Schroeter AL; Jordon RE
Arch Dermatol; 1978 Jun; 114(6):879-83. PubMed ID: 352270
[TBL] [Abstract][Full Text] [Related]
36. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
Jiang H; Lint TF; Gewurz H
Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
40. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
